April 2025 Newsletter

This month, we delve into one of the most groundbreaking developments in melanoma research: vaccines. Our spotlight article examines the potential of mRNA vaccines and explores the progress researchers have made toward creating a melanoma-specific vaccine.You’ll also find the latest installment of our Side Effect Central series—this issue covers lichen planus, an inflammatory skin condition that can appear during treatment with immunotherapy, with insights to help patients and caregivers understand and manage this potential side effect.
We also highlight a compelling study on indoor tanning behaviors, revealing how some individuals continue to tan indoors despite knowing the serious health risks—offering new understanding around the concept of behavioral addiction.
Whether you want to stay updated on the latest melanoma research, support a loved one facing the disease, or expand your understanding of it, this issue is filled with valuable insights and resources to guide you.
Read. Learn. Stay connected with AIM.
Recent Posts

RP1 Approved: A Long Road to a New Option for Patients

Patient Webinar: Understanding Your Second-Line Options

FDA Approves New Engineered Viral Immunotherapy for Patients with Treatment-Resistant Advanced Melanoma

AIM at Melanoma President Samantha Guild Receives SITC’s 2026 Tara Withington Public Service Award


